OSIVAX
  • COMPANY
    • ABOUT US
    • EXECUTIVE COMMITTEE
    • SCIENTIFIC ADVISORY BOARD
    • CLINICAL ADVISORY BOARD
    • BOARD OF DIRECTORS
    • PARTNERS
  • SCIENCE
  • PIPELINE
    • OVERVIEW
    • INFLUENZA - OVX836
    • CORONAVIRUS
  • NEWS
    • PRESS RELEASES
    • MEDIA COVERAGE
    • PUBLICATIONS
    • EVENTS
  • CONTACT
    • LEGAL MENTIONS
BOARD OF DIRECTORS
Picture

​

Dr Thomas JOUDINAUD, MD
Member of the Board of Directors

​


CEO of Ceres-Brain Therapeutics
​

​Thomas has broad experience in healthcare ranging from practicing medicine to research, ​development and commercialization ​of therapeutics
He is a Cardio-vascular Thoracic surgeon by training and have more than 10 years of strategy consulting experience specialized in healthcare.
Today, Thomas is CEO of Ceres-Brain Therapeutics, a biotech company spin-off from the CEA, and specialized in rare cerebral diseases.
Thomas was Board Member of the University Paris V René Descartes from 2012 to 2016.

Prior experience:
  • CEO, Ceres-Brain Therapeutics (2020 – current)
  • Partner, AEC Partners (2016-current)
  • Consultant to Principal, Boston Consulting Group (2009-2016)
  • Chief Resident, cardiac surgery, Bichat hospital, Paris (2006-2009)
  • Research fellow, The International Heart Institute of Montana Foundation, Saint Patrick Hospital, The University of Montana, Montana, USA (PhD thesis director Pr C. Duran)
  • Resident in surgery, Paris University Hospital
Education:
  • Medical degree from the Paris V University
  • The University of Montana, Cardiovascular Science, Pharmacy Department
return
Proudly powered by Weebly
  • COMPANY
    • ABOUT US
    • EXECUTIVE COMMITTEE
    • SCIENTIFIC ADVISORY BOARD
    • CLINICAL ADVISORY BOARD
    • BOARD OF DIRECTORS
    • PARTNERS
  • SCIENCE
  • PIPELINE
    • OVERVIEW
    • INFLUENZA - OVX836
    • CORONAVIRUS
  • NEWS
    • PRESS RELEASES
    • MEDIA COVERAGE
    • PUBLICATIONS
    • EVENTS
  • CONTACT
    • LEGAL MENTIONS